共 279 条
[1]
Sepanlou SG(2020)The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet Gastroenterol Hepatol 5 245-266
[2]
Safiri S(2018)Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Nat Rev Gastroenterol Hepatol. 15 11-20
[3]
Bisignano C(2019)NASH is the most rapidly growing etiology for acute-on-chronic liver failure-related hospitalization and disease burden in the United States: A Population-Based Study Liver Transplantation. 25 695-705
[4]
Ikuta KS(2011)Definition, epidemiology and magnitude of alcoholic hepatitis World J Hepatol. 3 108-113
[5]
Merat S(2020)The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Hepatol. 73 842-854
[6]
Saberifiroozi M(2017)Acute-on-chronic liver failure: an update Gut. 66 541-553
[7]
Younossi Z(2013)Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 144 1426-37, 37 e1-9-1065
[8]
Anstee QM(2016)Acute-on-chronic liver failure in cirrhosis Nat Rev Dis Primers. 2 16041-1820
[9]
Marietti M(2019)Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment Cancer Med. 8 1054-484
[10]
Hardy T(2019)Metabolomics approaches for the diagnosis and understanding of kidney diseases Metabolites. 9 34-1875